AGP Executive Report
Last update: 3 hours agoBattlefield Biotech: DTRA’s JSTO is pushing “assays on demand” by pairing portable Far Forward Biological Sequencing with in-theater DNA/RNA testing to speed detection of unknown biological threats. AI in Surgery: US surgeons used a Chinese Unitree humanoid robot for remotely controlled keyhole surgery in a pig gallbladder removal at UC San Diego, pointing to wider access for complex procedures. Medical Devices & Pharma: Sanofi’s Sarclisa Escena (isatuximab-irfc) got US FDA approval as the first multiple myeloma treatment delivered via an on-body injector, aiming to cut infusion time. Clinical Research: A new MonumenTAL-3 study rationale targets talquetamab in relapsed/refractory multiple myeloma, including combination strategies. Neurodegeneration Signals: A Finland study links early-onset dementia to declining work productivity up to 15 years before diagnosis, while other research reports dementia risk markers emerging years earlier. Environmental Health: Australia’s study finds elevated PFAS in young birds near industrial and military sites, with exposure peaking in newly fledged sparrows. Quantum Security: SEALSQ and Quobly signed a $5M deal to integrate post-quantum security into silicon-based quantum computing platforms. Tech Policy & Trust: A US watchdog launched a “Revolving Door Project” database tracking major AI players’ ties to the Trump administration.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
